Washington, July 23 (IANS) The benefits of the Johnson & Johnson Covid-19 vaccine far outweigh its potential risks amid an ongoing review of reports of a rare neurological disorder, according to an advisory panel to the US Centers for Disease Control and Prevention (CDC) on Thursday.There have been 8.1 cases of Guillain-Barre syndrome per 1 million doses, which is higher than expected in the general population and close to eight times the rate seen in Pfizer's and Moderna's shots, according to data presented at a meeting of CDC's Advisory Committee on Immunization Practices on Thursday.Guillain-Barre is a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis, according to the US Food and Drug Administration (FDA).The data came after the US Food and Drug Administration (FDA) announced a new warning on July 12 for the Johnson & Johnson shot after preliminary reports of Guillain-Barre syndrome in some recipients, the Xinhua news agency reported.About 100 preliminary reports of Guillain-Barre syndrome have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson vaccine in the US, according to the FDA.Of these reported cases, 95 were serious and required hospitalisation, and one was dead. --IANSint/rs
Poor lifestyle and dietary choices are two of the primary causes of coronary heart disease. While Covid-19 has impacted healthcare delivery across all specialities, cardiologists and heart surgeons have been cautioning regarding the virus' impact on a person's heart health, with or without surgery.
According to Sanjeeb Roy, senior intervention cardiologist, Jaipur, cases of poor heart health are increasing rapidly in the country. If the patient sees symptoms like shortness of breath, chest pain, fatigue, then the patient is at a risk of a cardiac arrest or heart attack, if there is a severe blockage in the arteries, it is treated by angioplasty or bypass surgery.
An angioplasty is an interventional procedure in which a stent is implanted in the patient without surgery. But sometimes even after having a stent implant, the patient may have to face some complications. According to one study, after implanting a normal metallic frame stent, there is a 15 to 30 per cent chance of it coming back. Apart from this, the patient has to take blood-thinning medicines for life, which also affects their quality of life.
However, to reduce all these complications, new technology like implanted stents will dissolve in the artery after two to three years. Biodegradable scaffold stent technology is very effective in reducing complications after angioplasty. This stent will dissolve in the artery two to three years after it is implanted and the patient's artery will return to its natural position, says the doctor.
"The biggest advantage of this to the patient is that there is no problem of affecting the functionality of the artery due to the placement of the stent. On the other hand, if there is a blockage back in his artery, then he can have angioplasty again. The biodegradable scaffold stent is a technology that does not use a metallic frame. This stent is made of polymers that will automatically dissolve in the body after two to three years of implantation."
"Advantages of biodegradable scaffold stents are: After the stent has dissolved, the patient will not need to take blood thinners for a long time; If there is a need to do angioplasty back in the same artery in the future, then there are no problems related to having stents already; Due to metallic stent implant, there will be no problems in tests like MRI, CT scan in this stent; The patient will feel psychological relief that there is no implant in his body," says Sanjeeb Roy, while mentioning a new technology.
Here's what to keep in mind for good heart health post angioplasty:
Avoid driving for a few weeks, and even riding in the car for long distances. As your body needs time to recuperate, make sure you're using pillows to prop yourself up and are supporting the delicate parts of your chest post-surgery.
Do not be in a rush to head back to an intense, high-stress life. Make sure your day has periods of activity interspersed with adequate periods of rest. Make sure you are working in an environment that can allow you to lie down if need be.
Shortness of breath may be experienced for a few days. Avoid exerting exercises and climbing stairs, and if this continues, speak to a family member and your doctor or surgeon.
It is likely that your doctor has recommended a change of diet for your post-surgery days. Make sure you follow it religiously and include greens and fruits as much as possible. This will aid recovery. Strictly avoid smoking and alcohol intake.
Read More► California confirms 1st human West Nile Virus death of 2021
Geneva, June 28 (IANS) Artificial Intelligence (AI) holds great promise for improving the delivery of healthcare and medicine worldwide, but only if ethics and human rights are put at the heart of its design, deployment, and use, according to a new World Health Organization (WHO) report published on Monday.The report Ethics and governance of artificial intelligence for health, cautions against overestimating the benefits of AI for health, especially when this occurs at the expense of core investments and strategies required to achieve universal health coverage."Like all new technology, artificial intelligence holds enormous potential for improving the health of millions of people around the world, but like all technology it can also be misused and cause harm," said Tedros Adhanom Ghebreyesus, WHO Director-General, in a statement."This important new report provides a valuable guide for countries on how to maximize the benefits of AI, while minimizing its risks and avoiding its pitfalls," he added.In many countries, AI is already being used to improve the speed and accuracy of diagnosis and screening for diseases; to assist with clinical care; strengthen health research and drug development, and support diverse public health interventions, such as disease surveillance, outbreak response, and health systems management.But, WHO's new report points out that opportunities are linked to challenges and risks, including unethical collection and use of health data; biases encoded in algorithms, and risks of AI to patient safety, cybersecurity, and the environment.The report,developed in consultations by a panel of international experts appointed by WHO, also emphasises that systems trained primarily on data collected from individuals in high-income countries may not perform well for individuals in low- and middle-income settings.Governments, providers, and designers must work together to address ethics and human rights concerns at every stage of an AI technology's design, development, and deployment, the WHO said.To limit the risks and maximise the opportunities intrinsic to the use of AI for health, the WHO also listed six principles for regulation and governance of the technology. The principles are: protecting human autonomy; promoting human well-being and safety and the public interest; ensuring transparency, explainability and intelligibility; fostering responsibility and accountability; ensuring inclusiveness and equity; and promoting AI that is responsive and sustainable.--IANSrvt/sdr/
Washington, June 24 (IANS) Advisers to the US Centers for Disease Control and Prevention (CDC) held a meeting to review rare heart problems in younger people immunised with Covid-19 vaccines.There have been more than 1,200 cases of myocarditis and pericarditis in young people who were administered with the Pfizer or Moderna vaccines, according to presentations published on Wednesday at the meeting of the CDC's Advisory Committee on Immunisation Practices.Clinical presentation of myocarditis cases following vaccination has been distinct, occurring most often within one week after dose two, with chest pain as the most common presentation, said Grace Lee, who chairs the committee's safety group.She added that CDC officials are gathering more data to fully understand the potential risks, how to manage it and whether there are any long-term issues, Xinhua news agency reported.There have been 267 cases of myocarditis and pericarditis reported after receiving one dose of the mRNA vaccines, and 827 reported cases after two doses through June 11, according to the CDC.There are 132 additional cases where the number of doses received is unknown, it said.Males under 30 make up the majority of the cases, and most cases appear to be mild, according to the CDC. --IANSksk/
Washington, June 22 (IANS) US Federal Reserve Chair Jerome Powell has said the Covid-19 pandemic continues to pose risks to the US economic outlook as the pace of vaccination has slowed."Progress on vaccinations has limited the spread of Covid-19 and will likely continue to reduce the effects of the public health crisis on the economy," Powell said in written testimony released Monday afternoon on the Fed's website, which was prepared for a Tuesday hearing before the House Select Subcommittee on the Coronavirus Crisis, Xinhua reported."However, the pace of vaccinations has slowed and new strains of the virus remain a risk. Continued progress on vaccinations will support a return to more normal economic conditions," he said.Powell's testimony came as public health experts warned that the highly contagious Delta variant continues threatening the US, especially in states with the lowest vaccination numbers.The Delta variant, which is believed to be more transmissible and cause more severe disease, could cause an upsurge in infections, but the levels will vary depending on the rates of vaccination in each area, said Scott Gottlieb, former commissioner of the US Food and Drug Administration.Powell also said in testimony that US inflation has increased notably in recent months as the economy continues to reopen."This reflects, in part, the very low readings from early in the pandemic falling out of the calculation; the pass-through of past increases in oil prices to consumer energy prices; the rebound in spending as the economy continues to reopen; and the exacerbating factor of supply bottlenecks," he explained."As these transitory supply effects abate, inflation is expected to drop back toward our longer-run goal," said the Fed chair.Core personal consumption expenditures price index, the Fed's preferred inflation measure, is expected to rise to 3 per cent by end of 2021, and then decelerate to 2.1 per cent over the next two years, according to the Fed's latest Summary of Economic Projections released last week. --IANSint/pgh
New Delhi, May 27 (IANS) As India battles the pandemic and states undergo lockdowns, the Reserve Bank of India (RBI) has said that the impact and the duration of the second wave of Covid-19 are the biggest threats to its growth estimates for the country for the ongoing financial year.In its annual report for FY21, the central bank has said that the onset of the second wave has triggered a raft of revisions to growth projections, with the consensus gravitating towards RBI's projection of 10.5 per cent for the year 2021-22. It had last projected a 26.2 per cent growth in Q1, 8.3 per cent in Q2, 5.4 percent in Q3 and 6.2 per cent in Q4.The report said: "The pandemic itself, especially the impact and duration of the second wave, is the biggest risk to this outlook."It, however, added that upsides also stem from the capex push by the government, rising capacity utilisation and the turnaround in capital goods imports.The apex bank observed that for April and early May 2021, available high frequency indicators present a mixed picture.While mobility and sentiment indicators have moderated, several activity indicators have held their own and shown resilience in the face of the second wave. GST collections crossed the Rs 1 lakh crore mark for the seventh consecutive month in April and notched up the highest level on record, suggesting that manufacturing and services production has been maintained.On the other hand, e-way bills moderated, pointing to mobility restrictions and possible slackening of GST collections in ensuing months. Slowing down of mobility is also reflected in toll collection volumes during April. In the agricultural sector, work demanded under the MGNREGA has tapered during the month, indicative of increased demand for farm labour.As regards industrial activity, electricity demand is stable. Transportation remains resilient as reflected in rising freight traffic supported by the pandemic-related surge in demand for essential medical supplies. On the external front, merchandise exports and imports have recorded growth rates of 195.7 per cent and 167.1 per cent in April, partly reflecting low base effect but also pointing to the revival of both external and domestic demand.The value of total digital transactions has been maintained in April.Financial conditions have generally remained congenial and supportive of the recovery, it said.--IANSrrb/in